Giant cell arteritis and mortality

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 64, Issue 3, 2009, Pages 365-369

  Crow, R Wade ^a   Katz, Bradley J ^a,b   Warner, Judith E A ^a,b   Alder, Stephen C ^b   Zhang, Kang ^a   Schulman, Susan ^c   Digre, Kathleen B ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c Links to Clinical Research   (United States)

Author keywords

Giant cell arteritis; Mortality; Temporal arteritis; Utah population database; Vasculitis

Indexed keywords

AGED; ARTICLE; BLOOD VESSEL BIOPSY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GIANT CELL ARTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; AGE; CASE CONTROL STUDY; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; HOSPITALIZATION; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROBABILITY; REFERENCE VALUE; REGISTER; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL; TEMPORAL ARTERY; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; TEMPORAL ARTERIES; UTAH;

EID: 64849086496     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/gln030     Document Type: Article

References (44)

1. Save-Soderbergh J, Malmvall BE, Andersson R, Bengtsson BA. Giant cell arteritis as a cause of death. Report of nine cases. JAMA. 1986;255:493-496. (Pubitemid 16146709)
2. Lie JT, Failoni DD, Davis DC, Jr Temporal arteritis with giant cell aortitis, coronary arteritis, and myocardial infarction. Arch Pathol Lab Med. 1986;110:857-860. (Pubitemid 16017793)
3. Hupp SL, Nelson GA, Zimmerman LE. Generalized giant-cell arteritis with coronary artery involvement and myocardial infarction. Arch Ophthalmol. 1990;108:1385-1387. (Pubitemid 20344687)
4. Morris CR, Scheib JS. Fatal myocardial infarction resulting from coronary arteritis in a patient with polymyalgia rheumatica and biopsy-proved temporal arteritis. A case report and review of the literature. Arch Intern Med. 1994;154:1158-1160.
5. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995;122:502-507.
6. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
7. Caselli RJ, Daube JR, Hunder GG, Whisnant JP. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology. 1988;38:685-689. (Pubitemid 18118700)
8. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88:162-167.
9. Missen GA. Involvement of the vertebro-carotid arterial system in giant-cell arteritis. J Pathol. 1972;106:P2-P3.
10. Wilkinson IM, Russell RW. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol. 1972;27:378-391.
11. Pascuzzi RM, Roos KL, Davis TE, Jr. Mental status abnormalities in temporal arteritis: a treatable cause of dementia in the elderly. Arthritis Rheum. 1989;32:1308-1311.
12. Unwin B, Williams CM, Gilliland W. Polymyalgia rheumatica and giant cell arteritis. Am Fam Physician. 2006;74:1547-1554. 1557-1558. (Pubitemid 44683391)
13. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003;139:505-515.
14. Gordon LK, Levin LA. Visual loss in giant cell arteritis. JAMA. 1998;280:385-386. (Pubitemid 28503227)
15. Hellman DB, Hunder GG. Giant cell arteritis and polymyalgia rheumatica. In: Harris ED, Budd RC, Genovese MC, Firestein GS, Sargent JS, Sledge CB, (eds). Kelley's Textbook of Rheumatology, 7th ed. Philadelphia, PA:Elsevier Saunders;2005:1343-1356.
16. Uriu SA, Reinecke RD. Temporal arteritis, steroid therapy, and pulmonary emboli. Arch Ophthalmol. 1973;90:355-357.
17. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3532-3537. (Pubitemid 37531920)
18. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ. 1989;299:549-550. (Pubitemid 19212333)
19. Hauser WA, Ferguson RH, Holley KE, Kurland LT. Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc. 1971;46:597-602.
20. Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J. 1979;24:111-117. (Pubitemid 9155714)
21. Graham E, Holland A, Avery A, Russell RW. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed). 1981;282:269-271.
22. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97:672-680.
23. Gouet D, Marechaud R, Alcalay M, et al. Survival in giant cell arteritis: a 14-year survey of 87 patients. J Rheumatol. 1985;12:1209-1210.
24. Andersson R, Malmvall BE, Bengtsson BA. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids. Acta Med Scand. 1986;220:361-364. (Pubitemid 17177766)
25. Bisgård C, Sloth H, Keiding N, Juel K. Excess mortality in giant cell arteritis. J Intern Med. 1991;230:119-123.
26. Nesher G, Sonnenblick M, Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol. 1994;21:1283-1286. (Pubitemid 24234666)
27. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996;100:193-196. (Pubitemid 26062514)
28. García-Porrúa C, Blanco FJ, Atanes A, Freire M, Graña J, Galdo F. Giant cell arteritis (GCA): survival analysis of 54 patients from Galicia, Spain. Arthritis Rheum. 1996;39:S64.
29. González-Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol. 1997;24:2171-2176. (Pubitemid 27474040)
30. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford). 2001;40:1238-1242. (Pubitemid 33100089)
31. Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol. 2002;29:737-742. (Pubitemid 34308459)
32. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51:264-268. (Pubitemid 38468712)
33. Wylie JE, Mineau GP. Biomedical databases: protecting privacy and promoting research. Trends Biotechnol. 2003;21:113-116.
34. Hachulla E, Boivin V, Pasturel-Michon U, et al. Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis. Clin Exp Rheumatol. 2001;19:171-176. (Pubitemid 32372453)
35. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York:Springer-Verlag;1997.
36. Bengtsson BA, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med Scand. 1981;209:337-345.
37. Kyle V, Hazelman BL. Stopping steroids in polymyalgia rheumatica and giant cell arteritis. BMJ. 1990;300:344-345. (Pubitemid 20048562)
38. Wright SD. Profile of Utah's aging population. In: Wright SD, ed. Utah Sourcebook on Aging. Salt Lake City, UT: Empire Publishing; 1998:47-76.
39. Center for Health Data, Utah Department of Health. Indicator Profile of Life Expectancy at Birth. Available at: http://ibis.health.utah.gov/indicator/ view/LifeExpect.UT-USSexYear.html Accessed June 4, 2008.
40. National Center for Health Statistics. Mortality Data from the National Vital Statistics System. Available at: http://www.cdc.gov/nchs/deaths.htm. Accessed June 1, 2008.
41. Rueda B, Roibas B, Martin J, Gonzalez-Gay MA. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. J Rheumatol. 2007;34:1535-1539. (Pubitemid 47067991)
42. Gonzalez-Gay MA, Rueda B, Vilchez JR, et al. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Rheumatology (Oxford). 2007;46:431-434. (Pubitemid 46344653)
43. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33:38-48. (Pubitemid 37046580)
44. Sieving PA, Collins FS. Genetic ophthalmology and the era of clinical care. JAMA. 2007;297:733-736.